Natural Product: NPC158051

Natural Product IDNPC158051
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Cyclaminorin
IUPAC Name n.a.
Synonyms Cyclaminorin
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL507039
PubChem CID 44566606
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey COSOLZZFQIVEIH-CDLHYRBUSA-N
Standard InCHI InChI=1S/C47H76O18/c1-41(2)25-7-11-44(5)26(8-12-47-27-15-42(3,20-50)13-14-46(27,21-60-47)28(51)16-45(44,47)6)43(25,4)10-9-29(41)64-40-37(65-39-36(58)34(56)31(53)23(18-49)62-39)32(54)24(19-59-40)63-38-35(57)33(55)30(52)22(17-48)61-38/h20,22-40,48-49,51-58H,7-19,21H2,1-6H3/t22-,23-,24+,25+,26-,27-,28-,29+,30-,31-,32+,33+,34+,35-,36-,37-,38+,39+,40+,42+,43+,44-,45+,46-,47+/m1/s1
SMILES CC1(C)[C@@H]2CC[C@]3(C)[C@H](CC[C@]45[C@@H]6C[C@](C)(CC[C@]6(CO5)[C@@H](C[C@@]34C)O)C=O)[C@@]2(C)CC[C@@H]1O[C@H]1[C@@H]([C@H]([C@H](CO1)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   928.5 Volume:   900.047
?
Van der Waals volume.
Dense:   1.032 LogP:   0.268
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.092
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.904
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   48.0
TPSA:   283.98
?
Topological Polar Surface Area.
H-Bond Acceptor:   18.0
H-Bond Donor:   10.0 Rings:   9.0
Heavy Atoms:   18.0

MedChem Properties

QED Drug-Likeness Score:   0.104 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.653 Fsp3:   0.979
MCE-18:   255.753
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.925 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.001
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.206 Promiscuous compounds:   0.019

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.393 MDCK Permeability:   -5.074
Pgp-inhibitor:   0.0 Pgp-substrate:   0.289
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.229
20% Bioavailability (F20%):   0.242 30% Bioavailability (F30%):   0.991
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.225 MRP1:   0.007
Plasma Protein Binding (PPB):   65.046% Volume Distribution (VD):   -0.378
Fu: 28.329%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.148
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.001 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.355
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.111 Half-life (T1/2):  3.219

ADMET: Toxicity

hERG Blockers:  0.007 hERG Blockers (10um):  0.01
Human Hepatotoxicity (H-HT):  0.694 Drug-induced Liver Injury (DILI):  0.846
AMES Toxicity:  0.997 Rat Oral Acute Toxicity:  0.013
Maximum Recommended Daily Dose:  0.005 Skin Sensitization:  1.0
Carcinogencity:  0.364 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.002
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.998
Hematotoxicity:  0.808 Drug-induced Nephrotoxicity:  0.889
Genotoxicity:  0.957 RPMI-8226 Immunitoxicity:  0.241
A549 Cytotoxicity:  0.886 Hek293 Cytotoxicity:  0.792
BCF:   0.935
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.513
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.211
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.328
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15237 Cyclamen mirabile Species Primulaceae Eukaryota n.a. n.a. n.a. PMID[9090874]
NPO15237 Cyclamen mirabile Species Primulaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO23245 Ardisia mamillata Species Primulaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO15237 Cyclamen mirabile Species Primulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO23245 Ardisia mamillata Species Primulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT188 Organism Candida parapsilosis Candida parapsilosis MIC = 80.0 ug.mL-1 PMID[9090874]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 46.2 10'-6M PMID[9090874]
NPT20 Organism Candida albicans Candida albicans MIC = 160.0 ug.mL-1 PMID[9090874]
NPT3153 Organism Kluyveromyces marxianus Kluyveromyces marxianus MIC = 160.0 ug.mL-1 PMID[9090874]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans MIC = 80.0 ug.mL-1 PMID[9090874]
NPT187 Organism Issatchenkia orientalis Pichia kudriavzevii MIC > 320.0 ug.mL-1 PMID[9090874]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 400.0 ug.mL-1 PMID[9090874]
NPT19 Organism Escherichia coli Escherichia coli MIC > 400.0 ug.mL-1 PMID[9090874]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC > 400.0 ug.mL-1 PMID[9090874]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 400.0 ug.mL-1 PMID[9090874]
NPT186 Organism Candida tropicalis Candida tropicalis MIC = 160.0 ug.mL-1 PMID[9090874]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC158051 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8936 High Similarity NPC40716
0.8876 High Similarity NPC18724
0.8778 High Similarity NPC224003
0.875 High Similarity NPC138219
0.875 High Similarity NPC475234
0.866 High Similarity NPC473688
0.8235 Intermediate Similarity NPC262567
0.8 Intermediate Similarity NPC475630
0.7959 Intermediate Similarity NPC253611
0.7959 Intermediate Similarity NPC488782
0.7925 Intermediate Similarity NPC231566
0.7879 Intermediate Similarity NPC267238
0.7879 Intermediate Similarity NPC77717
0.767 Intermediate Similarity NPC209798
0.7636 Intermediate Similarity NPC471626
0.76 Intermediate Similarity NPC158367
0.7477 Intermediate Similarity NPC471431
0.7327 Intermediate Similarity NPC119628
0.729 Intermediate Similarity NPC205129
0.7282 Intermediate Similarity NPC148593
0.7282 Intermediate Similarity NPC157571
0.7282 Intermediate Similarity NPC471373
0.7238 Intermediate Similarity NPC471375
0.7156 Intermediate Similarity NPC471425
0.7091 Intermediate Similarity NPC189575
0.7037 Intermediate Similarity NPC126753
0.7027 Intermediate Similarity NPC471429
0.7009 Intermediate Similarity NPC51579
0.6991 Remote Similarity NPC471427
0.6903 Remote Similarity NPC106701
0.6842 Remote Similarity NPC471424
0.6842 Remote Similarity NPC471426
0.6796 Remote Similarity NPC171741
0.6752 Remote Similarity NPC471428
0.6606 Remote Similarity NPC471374
0.6542 Remote Similarity NPC207693
0.6542 Remote Similarity NPC470623
0.6538 Remote Similarity NPC323231
0.6422 Remote Similarity NPC184805
0.6364 Remote Similarity NPC273189
0.6036 Remote Similarity NPC87393
0.6034 Remote Similarity NPC470622
0.5785 Remote Similarity NPC22709
0.5738 Remote Similarity NPC471430
0.5439 Remote Similarity NPC471435
0.5439 Remote Similarity NPC471434
0.5328 Remote Similarity NPC66513
0.5229 Remote Similarity NPC80640
0.5167 Remote Similarity NPC185466
0.5088 Remote Similarity NPC204392
0.5086 Remote Similarity NPC123796

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC158051 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data